Copyright Reports & Markets. All rights reserved.

Global Carcinoid Tumor Syndrome Treatment Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Carcinoid Tumor Syndrome Treatment
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Carcinoid Tumor Syndrome Treatment Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Chemotherapy
    • 1.3.3 Biological Therapy
    • 1.3.4 Radio Therapy
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Carcinoid Tumor Syndrome Treatment Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Home
  • 1.5 Global Carcinoid Tumor Syndrome Treatment Market Size & Forecast
    • 1.5.1 Global Carcinoid Tumor Syndrome Treatment Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Carcinoid Tumor Syndrome Treatment Sales Quantity (2018-2029)
    • 1.5.3 Global Carcinoid Tumor Syndrome Treatment Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Novartis AG
    • 2.1.1 Novartis AG Details
    • 2.1.2 Novartis AG Major Business
    • 2.1.3 Novartis AG Carcinoid Tumor Syndrome Treatment Product and Services
    • 2.1.4 Novartis AG Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Novartis AG Recent Developments/Updates
  • 2.2 Teva Pharmaceutical Industries Ltd.
    • 2.2.1 Teva Pharmaceutical Industries Ltd. Details
    • 2.2.2 Teva Pharmaceutical Industries Ltd. Major Business
    • 2.2.3 Teva Pharmaceutical Industries Ltd. Carcinoid Tumor Syndrome Treatment Product and Services
    • 2.2.4 Teva Pharmaceutical Industries Ltd. Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
  • 2.3 Mylan N.V.
    • 2.3.1 Mylan N.V. Details
    • 2.3.2 Mylan N.V. Major Business
    • 2.3.3 Mylan N.V. Carcinoid Tumor Syndrome Treatment Product and Services
    • 2.3.4 Mylan N.V. Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Mylan N.V. Recent Developments/Updates
  • 2.4 Ipsen Biopharmaceuticals, Inc
    • 2.4.1 Ipsen Biopharmaceuticals, Inc Details
    • 2.4.2 Ipsen Biopharmaceuticals, Inc Major Business
    • 2.4.3 Ipsen Biopharmaceuticals, Inc Carcinoid Tumor Syndrome Treatment Product and Services
    • 2.4.4 Ipsen Biopharmaceuticals, Inc Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Ipsen Biopharmaceuticals, Inc Recent Developments/Updates
  • 2.5 Sun Pharmaceutical Industries Ltd
    • 2.5.1 Sun Pharmaceutical Industries Ltd Details
    • 2.5.2 Sun Pharmaceutical Industries Ltd Major Business
    • 2.5.3 Sun Pharmaceutical Industries Ltd Carcinoid Tumor Syndrome Treatment Product and Services
    • 2.5.4 Sun Pharmaceutical Industries Ltd Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Sun Pharmaceutical Industries Ltd Recent Developments/Updates
  • 2.6 Amgen Inc.
    • 2.6.1 Amgen Inc. Details
    • 2.6.2 Amgen Inc. Major Business
    • 2.6.3 Amgen Inc. Carcinoid Tumor Syndrome Treatment Product and Services
    • 2.6.4 Amgen Inc. Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Amgen Inc. Recent Developments/Updates
  • 2.7 Entrinsic Health Solutions, Inc.
    • 2.7.1 Entrinsic Health Solutions, Inc. Details
    • 2.7.2 Entrinsic Health Solutions, Inc. Major Business
    • 2.7.3 Entrinsic Health Solutions, Inc. Carcinoid Tumor Syndrome Treatment Product and Services
    • 2.7.4 Entrinsic Health Solutions, Inc. Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Entrinsic Health Solutions, Inc. Recent Developments/Updates
  • 2.8 Endo Pharmaceuticals Inc.
    • 2.8.1 Endo Pharmaceuticals Inc. Details
    • 2.8.2 Endo Pharmaceuticals Inc. Major Business
    • 2.8.3 Endo Pharmaceuticals Inc. Carcinoid Tumor Syndrome Treatment Product and Services
    • 2.8.4 Endo Pharmaceuticals Inc. Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Endo Pharmaceuticals Inc. Recent Developments/Updates
  • 2.9 Sirtex SIR-Spheres Pty Ltd
    • 2.9.1 Sirtex SIR-Spheres Pty Ltd Details
    • 2.9.2 Sirtex SIR-Spheres Pty Ltd Major Business
    • 2.9.3 Sirtex SIR-Spheres Pty Ltd Carcinoid Tumor Syndrome Treatment Product and Services
    • 2.9.4 Sirtex SIR-Spheres Pty Ltd Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Sirtex SIR-Spheres Pty Ltd Recent Developments/Updates
  • 2.10 BTG International Ltd
    • 2.10.1 BTG International Ltd Details
    • 2.10.2 BTG International Ltd Major Business
    • 2.10.3 BTG International Ltd Carcinoid Tumor Syndrome Treatment Product and Services
    • 2.10.4 BTG International Ltd Carcinoid Tumor Syndrome Treatment Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 BTG International Ltd Recent Developments/Updates

3 Competitive Environment: Carcinoid Tumor Syndrome Treatment by Manufacturer

  • 3.1 Global Carcinoid Tumor Syndrome Treatment Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Carcinoid Tumor Syndrome Treatment Revenue by Manufacturer (2018-2023)
  • 3.3 Global Carcinoid Tumor Syndrome Treatment Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Carcinoid Tumor Syndrome Treatment by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Carcinoid Tumor Syndrome Treatment Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Carcinoid Tumor Syndrome Treatment Manufacturer Market Share in 2022
  • 3.5 Carcinoid Tumor Syndrome Treatment Market: Overall Company Footprint Analysis
    • 3.5.1 Carcinoid Tumor Syndrome Treatment Market: Region Footprint
    • 3.5.2 Carcinoid Tumor Syndrome Treatment Market: Company Product Type Footprint
    • 3.5.3 Carcinoid Tumor Syndrome Treatment Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Carcinoid Tumor Syndrome Treatment Market Size by Region
    • 4.1.1 Global Carcinoid Tumor Syndrome Treatment Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Carcinoid Tumor Syndrome Treatment Consumption Value by Region (2018-2029)
    • 4.1.3 Global Carcinoid Tumor Syndrome Treatment Average Price by Region (2018-2029)
  • 4.2 North America Carcinoid Tumor Syndrome Treatment Consumption Value (2018-2029)
  • 4.3 Europe Carcinoid Tumor Syndrome Treatment Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Carcinoid Tumor Syndrome Treatment Consumption Value (2018-2029)
  • 4.5 South America Carcinoid Tumor Syndrome Treatment Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Carcinoid Tumor Syndrome Treatment Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2018-2029)
  • 5.2 Global Carcinoid Tumor Syndrome Treatment Consumption Value by Type (2018-2029)
  • 5.3 Global Carcinoid Tumor Syndrome Treatment Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2018-2029)
  • 6.2 Global Carcinoid Tumor Syndrome Treatment Consumption Value by Application (2018-2029)
  • 6.3 Global Carcinoid Tumor Syndrome Treatment Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2018-2029)
  • 7.2 North America Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2018-2029)
  • 7.3 North America Carcinoid Tumor Syndrome Treatment Market Size by Country
    • 7.3.1 North America Carcinoid Tumor Syndrome Treatment Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Carcinoid Tumor Syndrome Treatment Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2018-2029)
  • 8.2 Europe Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2018-2029)
  • 8.3 Europe Carcinoid Tumor Syndrome Treatment Market Size by Country
    • 8.3.1 Europe Carcinoid Tumor Syndrome Treatment Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Carcinoid Tumor Syndrome Treatment Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Carcinoid Tumor Syndrome Treatment Market Size by Region
    • 9.3.1 Asia-Pacific Carcinoid Tumor Syndrome Treatment Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Carcinoid Tumor Syndrome Treatment Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2018-2029)
  • 10.2 South America Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2018-2029)
  • 10.3 South America Carcinoid Tumor Syndrome Treatment Market Size by Country
    • 10.3.1 South America Carcinoid Tumor Syndrome Treatment Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Carcinoid Tumor Syndrome Treatment Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Carcinoid Tumor Syndrome Treatment Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Carcinoid Tumor Syndrome Treatment Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Carcinoid Tumor Syndrome Treatment Market Size by Country
    • 11.3.1 Middle East & Africa Carcinoid Tumor Syndrome Treatment Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Carcinoid Tumor Syndrome Treatment Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Carcinoid Tumor Syndrome Treatment Market Drivers
  • 12.2 Carcinoid Tumor Syndrome Treatment Market Restraints
  • 12.3 Carcinoid Tumor Syndrome Treatment Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Carcinoid Tumor Syndrome Treatment and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Carcinoid Tumor Syndrome Treatment
  • 13.3 Carcinoid Tumor Syndrome Treatment Production Process
  • 13.4 Carcinoid Tumor Syndrome Treatment Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Carcinoid Tumor Syndrome Treatment Typical Distributors
  • 14.3 Carcinoid Tumor Syndrome Treatment Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Carcinoid Tumor Syndrome Treatment market size was valued at USD 1646.3 million in 2022 and is forecast to a readjusted size of USD 3295.3 million by 2029 with a CAGR of 10.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    Carcinoid tumor syndrome is a rare condition caused by a type of tumor called a carcinoid tumor. Carcinoid tumors are usually found in the gastrointestinal tract, but can also occur in other parts of the body such as the lungs and ovaries. These tumors produce hormones and chemicals, including serotonin, that can cause a variety of symptoms in affected individuals. Symptoms can include flushing of the skin, diarrhea, wheezing, abdominal pain, and heart palpitations.
    This report is a detailed and comprehensive analysis for global Carcinoid Tumor Syndrome Treatment market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Carcinoid Tumor Syndrome Treatment market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Carcinoid Tumor Syndrome Treatment market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Carcinoid Tumor Syndrome Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
    Global Carcinoid Tumor Syndrome Treatment market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Carcinoid Tumor Syndrome Treatment
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Carcinoid Tumor Syndrome Treatment market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Ipsen Biopharmaceuticals, Inc and Sun Pharmaceutical Industries Ltd, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market Segmentation
    Carcinoid Tumor Syndrome Treatment market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Chemotherapy
    Biological Therapy
    Radio Therapy
    Market segment by Application
    Hospital
    Clinic
    Home
    Major players covered
    Novartis AG
    Teva Pharmaceutical Industries Ltd.
    Mylan N.V.
    Ipsen Biopharmaceuticals, Inc
    Sun Pharmaceutical Industries Ltd
    Amgen Inc.
    Entrinsic Health Solutions, Inc.
    Endo Pharmaceuticals Inc.
    Sirtex SIR-Spheres Pty Ltd
    BTG International Ltd
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Carcinoid Tumor Syndrome Treatment product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Carcinoid Tumor Syndrome Treatment, with price, sales, revenue and global market share of Carcinoid Tumor Syndrome Treatment from 2018 to 2023.
    Chapter 3, the Carcinoid Tumor Syndrome Treatment competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Carcinoid Tumor Syndrome Treatment breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Carcinoid Tumor Syndrome Treatment market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
    Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Carcinoid Tumor Syndrome Treatment.
    Chapter 14 and 15, to describe Carcinoid Tumor Syndrome Treatment sales channel, distributors, customers, research findings and conclusion.

    Buy now